Trial Profile
Lastacaft Compared to Pataday and Placebo in Patients With Acute Allergic Conjunctivitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Sep 2015
Price :
$35
*
At a glance
- Drugs Alcaftadine (Primary) ; Olopatadine
- Indications Allergic conjunctivitis
- Focus Therapeutic Use
- Sponsors Allergan
- 20 Jan 2014 New trial record